What is Harmony Biosciences Holdings, Inc. (HRMY)?
Harmony Biosciences Holdings, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for neurological and rare diseases. The company’s portfolio includes products targeting conditions such as sleep disorders and other central nervous system-related ailments. Harmony Biosciences engages in research, clinical development, and regulatory activities to bring innovative treatments to market. It collaborates with healthcare professionals and regulatory agencies to facilitate patient access to its therapies. The company operates within the pharmaceutical industry, adhering to standards for drug development, manufacturing, and quality assurance. Its mission centers on addressing unmet medical needs through specialized therapeutic solutions.
Harmony Biosciences Holdings, Inc. Stock Price Today: Live Overview
The price today is shaped by ongoing session fluctuations for Harmony Biosciences Holdings, Inc., currently at $27.32. Prices have moved between $27.1 and $27.69, with a daily change percentage of -2.4829%.
FAQ: Harmony Biosciences Holdings, Inc. (HRMY)
What is the current price of HRMY stock?
The last recorded price is $27.32.
Does HRMY pay dividends?
Harmony Biosciences Holdings, Inc. pays dividends via cash distributions (if applicable).
Does HRMY have a formal corporate presence or regional headquarters in the UAE?
Harmony Biosciences Holdings, Inc. does not have an official office or subsidiary in the UAE and operates through partners or distributors.
What is HRMY best known for?
Harmony Biosciences Holdings, Inc. is most famous for its development of treatments for neurological disorders.
What assets are typically shown together with HRMY?
Commonly shown alongside HRMY: Takeda Pharmaceutical Company Limited, Biogen, L&G Multi
Latest shares articles



